Showing results (1131-1140 of 1,451) with videos related to

Sort By:
Pageof 146
Therapeutic Advances in Psychopharmacology|February 16, 2026
Impact of treatment with long‑acting injectable antipsychotics on hospitalization and relapse rates in schizophrenia spectrum disorders: a 3‑year follow-up mirror‑image studyRenato de Filippis, Matteo Aloi, Alfredo Cimino, et al.
JMIR Medical Informatics|November 7, 2023
Clinical Decision Support to Reduce Opioid Prescriptions for Dental Extractions using SMART on FHIR: Implementation ReportD Brad Rindal, Dhavan Prasad Pasumarthi, Vijayakumar Thirumalai, et al.
JAMA Psychiatry|April 22, 2026
Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia: A Randomized Clinical TrialAnna Eramo, Christoph U Correll, David P Walling, et al.
Journal of Neuroscience Research|February 3, 2021
Ethanol modulation of cerebellar neuroinflammation in a postnatal mouse model of fetal alcohol spectrum disordersCynthia J M Kane, James C Douglas, Tonya Rafferty, et al.
Neuromolecular Medicine|March 29, 2012
The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophreniaTaro Kishi, Yasuhisa Fukuo, Tomo Okochi, et al.
Melanoma Research|March 7, 2022
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patientsMichael M Wach, John R Subjeck, Xiang-Yang Wang, et al.
Nature Biotechnology|December 9, 2003
Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathwaysAinslie B Parsons, Renée L Brost, Huiming Ding, et al.
Emergency Medicine Journal : EMJ|February 17, 2021
Bed downtime: the novel use of a quality metric allows inpatient providers to improve patient flow from the emergency departmentBenjamin Bodnar, Erin M Kane, Hetal Rupani, et al.
Practical Radiation Oncology|March 4, 2019
Durable Improvement in Patient Safety Culture Over 5 Years With Use of High-volume Incident Learning SystemPehr E Hartvigson, Aaron S Kusano, Matthew J Nyflot, et al.
The American Journal of Psychiatry|March 4, 2006
DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patientsTodd Lencz, Delbert G Robinson, Ke Xu, et al.
Pageof 146